Annual Report 2010/11 - Sonova
Annual Report 2010/11 - Sonova Annual Report 2010/11 - Sonova
158 The following table shows the detailed breakdown of the outstanding warrants/options: Warrants EEAP 11 2) Warrants EEAP 10 3) Warrants EEAP 09 4) Warrants EEAP 08 5) Options EEAP 07 6) Total warrants 1) 31.3.2011 Total options Andy Rihs 250,000 250,000 450,000 300,000 3,000 1,250,000 3,000 William D. Dearstyne 250,000 7) 250,000 7) 337,500 7) 150,000 7) 3,000 8) 987,500 7) 3,000 8) Heliane Canepa 250,000 250,000 450,000 300,000 12,000 1,250,000 12,000 Dr Michael Jacobi 250,000 250,000 450,000 300,000 12,000 1,250,000 12,000 Robert F. Spoerry 250,000 250,000 450,000 300,000 12,000 1,250,000 12,000 Anssi Vanjoki 250,000 250,000 500,000 Ronald van der Vis 250,000 250,000 500,000 John J. Zei 250,000 7) 250,000 7) Total 2,000,000 1,750,000 2,137,500 1,350,000 42,000 7,237,500 42,000 1) Exercise ratio between warrants and options: 25:1 (see also Note 30 in the consolidated financial statements). 2) Strike price CHF 118.40, blocking period 1.3.2011 – 28.2.2015, whereas one tranche being released each year, exercise period 1.3.2012 – 29.2.2016. 3) Strike price CHF 131.00, blocking period 1.3.2010 – 28.2.2014, whereas one tranche being released each year, exercise period 1.3.2011 – 28.2.2015. 4) Strike price CHF 56.00, blocking period 1.3.2009 – 28.2.2013, whereas one tranche being released each year, exercise period 1.3.2010 – 28.2.2014. 5) Strike price CHF 96.00, blocking period 1.3.2008 – 29.2.2012, whereas one tranche being released each year, exercise period 1.3.2009 – 28.2.2013. 6) Strike price CHF 95.05, blocking period 1.2.2007 – 31.1./28.2.2011, whereas one tranche being released each year, exercise period 1.2.2008 – 31.1./29.2.2012. 7) WARs (WARs grant the right to participate in the appreciation of the Sonova shares without issuance of shares). 8) SARs (SARs grant the right to participate in the appreciation of the Sonova shares without issuance of shares). Warrants EEAP 10 2) Warrants EEAP 09 3) Warrants EEAP 08 4) Options EEAP 07 5) Options EEAP 06 6) Total warrants 1) 31.3.2010 Total options Andy Rihs 250,000 450,000 300,000 12,000 12,000 1,000,000 24,000 William D. Dearstyne 250,000 7) 450,000 7) 300,000 7) 12,000 8) 12,000 1,000,000 7) 24,000 8) Heliane Canepa 250,000 450,000 300,000 12,000 3,000 1,000,000 15,000 Dr Michael Jacobi 250,000 450,000 300,000 12,000 3,000 1,000,000 15,000 Robert F. Spoerry 250,000 450,000 300,000 12,000 12,000 1,000,000 24,000 Anssi Vanjoki 250,000 250,000 Ronald van der Vis 250,000 250,000 Total 1,750,000 2,250,000 1,500,000 60,000 42,000 5,500,000 102,000 1) Exercise ratio between warrants and options: 25:1 (see also Note 30 in the consolidated financial statements). 2) Strike price CHF 131.00, blocking period 1.3.2010 – 28.2.2014, whereas one tranche being released each year, exercise period 1.3.2011 – 28.2.2015. 3) Strike price CHF 56.00, blocking period 1.3.2009 – 28.2.2013, whereas one tranche being released each year, exercise period 1.3.2010 – 28.2.2014. 4) Strike price CHF 96.00, blocking period 1.3.2008 – 29.2.2012, whereas one tranche being released each year, exercise period 1.3.2009 – 28.2.2013. 5) Strike price CHF 95.05, blocking period 1.2.2007 – 31.1./28.2.2011, whereas one tranche being released each year, exercise period 1.2.2008 – 31.1./29.2.2012. 6) Strike price CHF 63.25, blocking period 1.2.2006 – 31.01.2010, whereas one tranche being released each year, exercise period 1.2.2007 – 31.1.2011. 7) WARs (WARs grant the right to participate in the appreciation of the Sonova shares without issuance of shares). 8) Thereof 12,000 SARs (SARs grant the right to participate in the appreciation of the Sonova shares without issuance of shares). For shareholdings of Dr Valentin Chapero Rueda see shareholdings of members of the management Board.
FINANCIAL STATEmENTS OF SONOVA HOLDING AG 159 Shareholdings of the management Board As of march 31, 2011, the members of the management Board and persons closely linked to them held directly and indirectly 3,030 Sonova shares, 9,905,500 warrants and 13,335 options. The following table shows the shareholdings of the individual members of the management Board and persons closely linked to them: 31.3.2011 31.3.2010 Shares Warrants 1) Options Shares Warrants 1) Options Alexander Zschokke 1,537,500 1,231,250 5,576 Paul Thompson 1,537,500 1,231,250 4,000 Hansjürg Emch2) 1,700 661,000 Sarah Kreienbühl 1,738,000 790 1,587,500 11,750 Dr Hans Leysieffer 1,231,250 4,000 Ignacio Martinez 1,550,000 4,000 1,525,000 23,000 Maarten Barmentlo3) 869,000 Hans Mehl 1,330 2,012,500 8,545 830 1,450,000 70,000 Dr Valentin Chapero Rueda4) 660,000 Oliver Walker4) 1,611,250 5,000 Cameron Hay5) 1,152,500 13,750 Total 3,030 9,905,500 13,335 830 11,020,000 797,076 1) Exercise ratio between warrants and options: 25:1 (see also Note 30 in the consolidated financial statements). 2) member of the management Board since march 2011. 3) member of the management Board since January 2011. 4) member of the management Board until march 2011. 5) member of the management Board until November, 2010. The following table shows the detailed breakdown of the outstanding warrants/options: Warrants EEAP 11 2) Warrants EEAP 10 3) Warrants EEAP 09 4) Warrants EEAP 08 5) Options EEAP 07 6) Total warrants 1) 31.3.2011 Total options Alexander Zschokke 562,500 562,500 312,500 100,000 1,537,500 Paul Thompson 562,500 562,500 312,500 100,000 1,537,500 Hansjürg Emch 475,000 186,000 661,000 Sarah Kreienbühl 562,500 562,500 513,000 100,000 790 1,738,000 790 Ignacio Martinez 562,500 562,500 312,500 112,500 4,000 1,550,000 4,000 Maarten Barmentlo 475,000 394,000 869,000 Hans Mehl 562,500 450,000 500,000 500,000 8,5457) 2,012,500 8,545 Total warrants/options 3,762,500 3,280,000 1,950,500 912,500 13,335 9,905,500 13,335 1) Exercise ratio between warrants and options: 25:1 (see also Note 30 in the consolidated financial statements). 2) Strike price CHF 118.40, blocking period 1.3.2011 – 28.2.2015, whereas one tranche being released each year, exercise period 1.3.2012 – 29.2.2016. 3) Strike price CHF 131.00, blocking period 1.3.2010 – 28.2.2014, whereas one tranche being released each year, exercise period 1.3.2011 – 28.2.2015. 4) Strike price CHF 56.00, blocking period 1.3.2009 – 28.2.2013, whereas one tranche being released each year, exercise period 1.3.2010 – 28.2.2014. 5) Strike price CHF 96.00, blocking period 1.3.2008 – 29.2.2012, whereas one tranche being released each year, exercise period 1.3.2009 – 28.2.2013. 6) Strike price CHF 95.05, blocking period 1.2.2007 – 30.9.2011, whereas one tranche being released each year, exercise period 1.2.2008 – 31.5.2012. 7) These options were granted to Hans mehl at commencement of employment on April 1, 2007.
- Page 112 and 113: 108 Consolidated Changes in Equity
- Page 114 and 115: 110 5. segment information segment
- Page 116 and 117: 112 6. other expenses, net 1,000 ch
- Page 118 and 119: 114 Deferred tax assets and (liabil
- Page 120 and 121: 116 11. cash and cash equivalents 1
- Page 122 and 123: 118 14. other receivables and prepa
- Page 124 and 125: 120 the increase in property, plant
- Page 126 and 127: 122 1,000 cHf 31.3.2010 Cost Goodwi
- Page 128 and 129: 124 20. Provisions 1,000 cHf 31.3.2
- Page 130 and 131: 126 23. non-current financial liabi
- Page 132 and 133: 128 foreign currency sensitivity an
- Page 134 and 135: 130 the following table summarizes
- Page 136 and 137: 132 caPital RisK manaGement it is t
- Page 138 and 139: 134 the annual General shareholders
- Page 140 and 141: 136 28. Related party transactions
- Page 142 and 143: 138 Amounts recognized in the incom
- Page 144 and 145: 140 30. Employee share option and s
- Page 146 and 147: 142 The fair value of options/warra
- Page 148 and 149: 144 Changes in outstanding shares/R
- Page 150 and 151: 146 36. list of significant consoli
- Page 152 and 153: 148 REPORT OF THE STATuTORY AuDITOR
- Page 154 and 155: 150 Income Statements 1,000 CHF Not
- Page 156 and 157: 152 NOTES TO THE FINANCIAL STATEmEN
- Page 158 and 159: 154 Executive Equity Award Plan The
- Page 160 and 161: 156 Compensation to the management
- Page 164 and 165: 160 Warrants EEAP 10 2) Warrants/ o
- Page 166 and 167: 162 Company name Activity Domicile
- Page 168 and 169: 164 Appropriation of Available Earn
- Page 170 and 171: 166 REPORT OF THE STATUTORy AUDITOR
- Page 173 and 174: Disclaimer This report contains for
158<br />
The following table shows the detailed breakdown of the outstanding warrants/options:<br />
Warrants EEAP<br />
<strong>11</strong> 2)<br />
Warrants EEAP<br />
10 3)<br />
Warrants EEAP<br />
09 4)<br />
Warrants EEAP<br />
08 5)<br />
Options EEAP<br />
07 6)<br />
Total<br />
warrants 1)<br />
31.3.20<strong>11</strong><br />
Total<br />
options<br />
Andy Rihs 250,000 250,000 450,000 300,000 3,000 1,250,000 3,000<br />
William D. Dearstyne 250,000 7) 250,000 7) 337,500 7) 150,000 7) 3,000 8) 987,500 7) 3,000 8)<br />
Heliane Canepa 250,000 250,000 450,000 300,000 12,000 1,250,000 12,000<br />
Dr Michael Jacobi 250,000 250,000 450,000 300,000 12,000 1,250,000 12,000<br />
Robert F. Spoerry 250,000 250,000 450,000 300,000 12,000 1,250,000 12,000<br />
Anssi Vanjoki 250,000 250,000 500,000<br />
Ronald van der Vis 250,000 250,000 500,000<br />
John J. Zei 250,000 7) 250,000 7)<br />
Total 2,000,000 1,750,000 2,137,500 1,350,000 42,000 7,237,500 42,000<br />
1) Exercise ratio between warrants and options: 25:1 (see also Note 30 in the consolidated financial statements).<br />
2) Strike price CHF <strong>11</strong>8.40, blocking period 1.3.20<strong>11</strong> – 28.2.2015, whereas one tranche being released each year, exercise period 1.3.2012 – 29.2.2016.<br />
3) Strike price CHF 131.00, blocking period 1.3.<strong>2010</strong> – 28.2.2014, whereas one tranche being released each year, exercise period 1.3.20<strong>11</strong> – 28.2.2015.<br />
4) Strike price CHF 56.00, blocking period 1.3.2009 – 28.2.2013, whereas one tranche being released each year, exercise period 1.3.<strong>2010</strong> – 28.2.2014.<br />
5) Strike price CHF 96.00, blocking period 1.3.2008 – 29.2.2012, whereas one tranche being released each year, exercise period 1.3.2009 – 28.2.2013.<br />
6) Strike price CHF 95.05, blocking period 1.2.2007 – 31.1./28.2.20<strong>11</strong>, whereas one tranche being released each year, exercise period 1.2.2008 – 31.1./29.2.2012.<br />
7) WARs (WARs grant the right to participate in the appreciation of the <strong>Sonova</strong> shares without issuance of shares).<br />
8) SARs (SARs grant the right to participate in the appreciation of the <strong>Sonova</strong> shares without issuance of shares).<br />
Warrants EEAP<br />
10 2)<br />
Warrants EEAP<br />
09 3)<br />
Warrants EEAP<br />
08 4)<br />
Options EEAP<br />
07 5)<br />
Options EEAP<br />
06 6)<br />
Total<br />
warrants 1)<br />
31.3.<strong>2010</strong><br />
Total<br />
options<br />
Andy Rihs 250,000 450,000 300,000 12,000 12,000 1,000,000 24,000<br />
William D. Dearstyne 250,000 7) 450,000 7) 300,000 7) 12,000 8) 12,000 1,000,000 7) 24,000 8)<br />
Heliane Canepa 250,000 450,000 300,000 12,000 3,000 1,000,000 15,000<br />
Dr Michael Jacobi 250,000 450,000 300,000 12,000 3,000 1,000,000 15,000<br />
Robert F. Spoerry 250,000 450,000 300,000 12,000 12,000 1,000,000 24,000<br />
Anssi Vanjoki 250,000 250,000<br />
Ronald van der Vis 250,000 250,000<br />
Total 1,750,000 2,250,000 1,500,000 60,000 42,000 5,500,000 102,000<br />
1) Exercise ratio between warrants and options: 25:1 (see also Note 30 in the consolidated financial statements).<br />
2) Strike price CHF 131.00, blocking period 1.3.<strong>2010</strong> – 28.2.2014, whereas one tranche being released each year, exercise period 1.3.20<strong>11</strong> – 28.2.2015.<br />
3) Strike price CHF 56.00, blocking period 1.3.2009 – 28.2.2013, whereas one tranche being released each year, exercise period 1.3.<strong>2010</strong> – 28.2.2014.<br />
4) Strike price CHF 96.00, blocking period 1.3.2008 – 29.2.2012, whereas one tranche being released each year, exercise period 1.3.2009 – 28.2.2013.<br />
5) Strike price CHF 95.05, blocking period 1.2.2007 – 31.1./28.2.20<strong>11</strong>, whereas one tranche being released each year, exercise period 1.2.2008 – 31.1./29.2.2012.<br />
6) Strike price CHF 63.25, blocking period 1.2.2006 – 31.01.<strong>2010</strong>, whereas one tranche being released each year, exercise period 1.2.2007 – 31.1.20<strong>11</strong>.<br />
7) WARs (WARs grant the right to participate in the appreciation of the <strong>Sonova</strong> shares without issuance of shares).<br />
8) Thereof 12,000 SARs (SARs grant the right to participate in the appreciation of the <strong>Sonova</strong> shares without issuance of shares).<br />
For shareholdings of Dr Valentin Chapero Rueda see shareholdings of members of the management Board.